Testing NA-931 and tirzepatide for weight loss in overweight or obese adults
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial is testing two drugs, NA-931 and tirzepatide, to see if they are safe and help adults who are overweight or obese lose weight. You may qualify if you have a high body mass index (BMI) and have tried to lose weight before without lasting success.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- Your body mass index (BMI) is 30 or higher, or 27 or higher with a weight-related health problem like high blood pressure or sleep apnea.
- Your weight has been stable (within 11 pounds) for the past 3 months and is below 330 pounds.
- You have tried to lose weight on your own at least once but did not keep it off.
- You are not currently taking any weight loss medication (in the last 30 days).
- You do not have diabetes requiring medication, or if you do, your hemoglobin A1c is less than 6.5%.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called tirzepatide (a once-weekly injection) to help teenagers with obesity and related health conditions lose weight. It aims to see if the drug is safe and effective for this age group.
This trial tests an experimental drug called RN3161 to see if it helps with weight loss in people with overweight or obesity. It can be taken alone or with another weight-loss medication (tirzepatide).
This study tests if tirzepatide helps people with obesity lose weight, whether or not they have type 2 diabetes. It aims to see how safe and effective the drug is.
This trial tests if tirzepatide is more effective than standard obesity treatments for adults who have a BMI between 30 and 35 and one weight-related health condition, but do not have diabetes. The goal is to help you lose weight.
This Phase 2 study tests whether tirzepatide can improve how your body handles fat (especially in people with overweight or obesity) and reduce fat-related “lipotoxicity.” It may help with body fat function and related health markers, but you must meet specific health and medication rules.
This trial examines how well tirzepatide works for weight loss in people with obesity, and how it's actually used in daily life. It may be an option if you haven't tried other obesity treatments and don't have diabetes.
Hear when a new Obesity and Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.